Announcements

Shannon Thyme Klinger, Chief Legal Officer of Moderna, Inc. (NASDAQ:MRNA), filed a Form 4 on August 31, 2026, reporting restricted stock unit vesting events and related share withholdings on August 27 and August 28, 2026.

Andrew M. Dahl, SVP and Corporate Controller at Edwards Lifesciences Corp, filed a Form 4 on August 31, 2026, reporting the sale of 544 shares of common stock under the company's Employee Stock Purchase Plan.

A Form 4 filed on August 31, 2026 discloses that Keith E. Bass, a director of Rayonier Inc. (NYSE:RYN), acquired 1,136 common shares on August 28, 2026 as payment of his quarterly retainer in lieu of cash for Q2 2026.

Subhashis Banerjee, Chief Medical Officer of Artiva Biotherapeutics, Inc. (NASDAQ:ARTV), filed a Form 4 on August 31, 2026, disclosing the exercise of stock options and the sale of common stock on August 27, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Frances Arnold, a director of Alphabet Inc. (NASDAQ:GOOGL), filed a Form 4 on August 31, 2026, disclosing the sale of 82 shares of Class C Capital Stock on August 28, 2026, along with reporting four separate holdings of Class C Google Stock Units.

Sean D. Keohane, President and CEO of Cabot Corporation, filed a Form 4 on August 31, 2026, reporting the exercise of employee stock options and a same-day sale of 134,895 shares of common stock on August 28, 2026.

A Form 4 filed on August 31, 2026 with the SEC discloses that Jacob Maas, Executive Vice President of Graham Holdings Co (NYSE:GHC), reported two transactions in Class B Common Stock on August 28, 2026, stemming from a price-based restricted stock unit award.